Freestanding three-dimensional (3D) graphene foam has been fabricated via a Chemical Vapour Deposition (CVD) methodology which has a macroscopic structure with microscopic (graphene) features. The 3D graphene macrostructure is characterised with SEM, EDX, XPS and Raman spectroscopy and is found to comprise pristine graphene (O/C of 0.05) which is in the range of mono- to few-layered graphene sheets and is thus termed quasi-graphene. This unique 3D graphene foam is electrochemically explored in both aqueous and non-aqueous solutions and compared to a freestanding 3D reticulated vitreous carbon (RVC) foam alternative. In aqueous solutions, the 3D graphene foam exhibits poor voltammetric responses. Contact angle measurements reveal the 3D graphene to exhibit a value of 120° representing quasi-super-hydrophobicity. Consequently the freestanding 3D graphene foam is found to give rise to significantly improved voltammetric signatures in non-aqueous media (ionic liquids) over that of a freestanding 3D RVC alternative. The 3D graphene foam provides a promising and beneficial architecture over 2D pristine graphene due to its ease of use and macroscopic/microscopic structure, which will have wide implementation in the field of electrochemistry.
A simple and highly selective electrochemical method was developed for the single or simultaneous determination of dopamine (DA) and epinephrine (EP) in human body fluids using a glassy carbon electrode modified with nickel oxide nanoparticles and carbon nanotubes within a dihexadecylphosphate film using square-wave voltammetry (SWV) or differential-pulse voltammetry (DPV). Using DPV with the proposed electrode, a separation of ca. 360 mV between the peak reduction potentials of DA and EP present in binary mixtures was obtained. The analytical curves for the simultaneous determination of dopamine and epinephrine showed an excellent linear response, ranging from 7.0 × 10−8 to 4.8 × 10−6 and 3.0 × 10−7 to 9.5 × 10−6 mol L−1 for DA and EP, respectively. The detection limits for the simultaneous determination of DA and EP were 5.0 × 10−8 mol L−1 and 8.2 × 10−8 mol L−1, respectively. The proposed method was successfully applied in the simultaneous determination of these analytes in human body fluid samples of cerebrospinal fluid, human serum and lung fluid.